On September 30, Marc Ullman spoke at the Natural Products Insider webinar “Hemp Evolution: Surviving the imminent regulatory shockwave.”

The presentation discussed mitigating legal risks and thriving in the multi-billion dollar hemp phytocannabinoid market.

The video is still available to view. Click here to register and watch.

On October 7, 2020, Marc Ullman will be a panelist at the webinar “Your COVID Communications Could be Illegal: Here’s How to Avoid FDA & FTC Trouble.”

The event is hosted by the American Association of Naturopathic Physicians and is free to attend.

In this program, you’ll learn about:

• The laws governing permissible language

Brian Bank, Michelle Bholan and Geoffrey Kaiser secured pre-answer dismissal of various False Claims Act claims brought against three New York nephrologists by a relator, also a nephrologist.

The action, which the relator brought on behalf of the United States of America under the False Claims Act’s qui tam provisions, alleged two theories against the

Marc Ullman was interviewed for the Natural Products Insider article, “FDA, supplement manufacturer debate NDI import alert request.”

The article discusses why the FDA should issue an import alert on beta-alanine ingredients manufactured in China.

To read the full article, click here.

Eric Fader was cited in the Part B News article, “Latest Section 1557 rule rescinds trans patients’ rights, but SCOTUS has other ideas.”

The article discusses the recent Section 1557 final rule which seems to removes civil rights from trans or non binary patients seeking federal payer coverage for treatment.

Click here to read the

Marc Ullman was cited in Nutritional Outlook’s article, “High anxiety: Will CBD ever be legal in foods and beverages?”

The article discusses whether or not the FDA will ever approve the use of CBD in foods and beverages. Currently, it is not a lawful ingredient. Ullman provided advice on the procedures necessary to prove the

On April 21, 2020, Nancy Del Pizzo moderated and presented on a live webinar panel titled: The Evolving Landscape of Privacy and Cybersecurity. She was joined by co-presenters Stephen E. Breidenbach and R. Jason Straight. The one-hour presentation is available for re-viewing and CLE by the American Bar Association.

The webinar was sponsored by the

On April 6, Rivkin Radler’s Eric Fader presented a COVID-19 Business Briefing on Telehealth. The Briefing covered recent developments in federal and state law and policy, and changes in private insurers’ policies, that have been aimed at encouraging the use of telehealth during the current public health emergency.

This Business Briefing was the second in

Marc Ullman spoke with NutraingredientsUSA.com about the impact of the ABH recall on the entire nutritional supplements industry, as thousands of products were recalled as part of a consent decree, which covered 859 businesses and brands. ABH is a contract manufacturer that was sanctioned by the FDA for repeatedly failing to comply with regulations.

Marc

Update

The U.S. Department of the Treasury published additional guidance, in the form of FAQs. To view the FAQ sheet, click here.

————————————————————

On April 6, Rivkin Radler’s Robert Iseman presented a COVID-19 Business Briefing on the Paycheck Protection Program that was created under the Coronavirus Aid, Relief and Economic Security Act (CARES Act). Administered